Showing results (81-90 of 100) with videos related to
Sort By:
Pageof 10
Acta Psychiatrica Scandinavica|November 1, 1992
Debrisoquine oxidation phenotype and neuroleptic-induced dystonic reactionsE Spina, V Sturiale, S Valvo, et al.Minerva Pediatrica|May 16, 2014
[Safety and tolerability of psychotropic medications in childhood: preliminary data of a pharmacovigilance study]A Magazù, G Masi, E Germanò, et al.Cancer Letters|April 28, 2018
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell linesL Gelsomino, S Panza, C Giordano, et al.Therapeutic Drug Monitoring|August 15, 2000
Plasma concentrations of risperidone and 9-hydroxyrisperidone: effect of comedication with carbamazepine or valproateE Spina, A Avenoso, G Facciolà, et al.Therapeutic Drug Monitoring|January 1, 1988
Evaluation of tricyclic antidepressant plasma levels by an automated enzyme immunoassay (EMIT) in comparison to a high-performance liquid chromatographic methodA Fazio, C Artesi, C Lorefice, et al.Psychopharmacology|February 9, 2000
Relationship between plasma concentrations of clozapine and norclozapine and therapeutic response in patients with schizophrenia resistant to conventional neurolepticsE Spina, A Avenoso, G Facciolà, et al.Psychopharmacology|February 24, 2001
Relationship between plasma risperidone and 9-hydroxyrisperidone concentrations and clinical response in patients with schizophreniaE Spina, A Avenoso, G Facciolà, et al.Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|January 28, 2003
Quetiapine versus clozapine: a preliminary report of comparative effects on dopaminergic psychosis in patients with Parkinson's diseaseL Morgante, A Epifanio, E Spina, et al.Acta Psychiatrica Scandinavica|September 5, 2001
CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosagesJ Kirchheiner, K Brøsen, M L Dahl, et al.International Clinical Psychopharmacology|January 1, 1994
Adjunctive fluoxetine in the treatment of negative symptoms in chronic schizophrenic patientsE Spina, P De Domenico, C Ruello, et al.Pageof 10